blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1210076

EP1210076 - DRUG THERAPY OF THE RESTLESS LEG SYNDROME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.07.2003
Database last updated on 19.07.2024
Most recent event   Tooltip26.06.2009Change - representativepublished on 29.07.2009  [2009/31]
Applicant(s)For all designated states
Boehringer Ingelheim Pharma KG
55216 Ingelheim am Rhein / DE
[2002/23]
Inventor(s)01 / BRECHT, Hans-Michael
Turnerstrasse 12
D-55218 Ingelheim am Rhein / DE
 [2002/23]
Representative(s)Laudien, Dieter, et al
Boehringer Ingelheim GmbH ZA Patente Postfach 200
55216 Ingelheim am Rhein / DE
[2009/31]
Former [2002/23]Laudien, Dieter, Dr., et al
c/o Boehringer Ingelheim GmbH
55216 Ingelheim / DE
Application number, filing date00956413.909.08.2000
[2002/23]
WO2000EP07719
Priority number, dateDE199913882319.08.1999         Original published format: DE 19938823
[2002/23]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO0113903
Date:01.03.2001
Language:DE
[2001/09]
Type: A2 Application without search report 
No.:EP1210076
Date:05.06.2002
Language:DE
The application published by WIPO in one of the EPO official languages on 01.03.2001 takes the place of the publication of the European patent application.
[2002/23]
Search report(s)International search report - published on:EP23.08.2001
ClassificationIPC:A61K31/195, A61K31/415, A61P25/00
[2002/23]
CPC:
A61K45/06 (EP,US); A61K31/55 (KR); A61P19/00 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/14 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/23]
Extension statesALNot yet paid
LT19.03.2002
LV19.03.2002
MKNot yet paid
RO19.03.2002
SI19.03.2002
TitleGerman:BEHANDLUNG DES RESTLESS LEG SYNDROMS MIT EINER KOMBINATION VON CLONIDIN UND OPIOID[2002/23]
English:DRUG THERAPY OF THE RESTLESS LEG SYNDROME[2002/23]
French:TRAITEMENT THERAPEUTIQUE DU SYNDROME DES JAMBES SANS REPOS[2002/23]
Entry into regional phase19.03.2002National basic fee paid 
19.03.2002Designation fee(s) paid 
19.03.2002Examination fee paid 
Examination procedure22.12.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
19.03.2002Examination requested  [2002/23]
28.10.2002Despatch of a communication from the examining division (Time limit: M04)
03.03.2003Application deemed to be withdrawn, date of legal effect  [2003/36]
07.04.2003Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2003/36]
Fees paidPenalty fee
Additional fee for renewal fee
31.08.200203   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP0256798  (BOC INC [US]) [X] 1-7,16-18,22-29* abstract *;
 [X]WO9924023  (GRUENENTHAL GMBH [DE], et al) [X] 1-7,16-18,22-29 * page 4, lines 14-25; claims 2-4 *;
 [PX]WO0025821  (HEDNER JAN [SE], et al) [PX] 1-29 * abstract * * page 13; claims 9,10,13,14,16,19,20 *;
 [E]WO0054773  (NITROMED INC [US], et al) [E] 1-29 * page 14, lines 18-20; claims 3,59 *;
 [Y]  - ZOE A. ET AL, "High-dose clonidine in a case of restless legs syndrome.", ANNALS OF PHARMACOTHERAPY, (1994) 28/7-8 (878-881)., XP000989816 [Y] 1-29 * abstract * * page 879, column 2, paragraph 3 *
 [Y]  - COLLADO-SEIDEL V. ET AL, "Aetiology and treatment of restless legs syndrome.", CNS DRUGS, (1999) 12/1 (9-20)., XP000989833 [Y] 1-29 * abstract * * page 14 - page 15 *

DOI:   http://dx.doi.org/10.2165/00023210-199912010-00002
 [PX]  - SCHENK C. H. ET AL, "Parasomnias. Managing bizarre sleep related behavior disorders", POSTGRADUATE MEDICINE, (200003), vol. 107, no. 3, XP000989817 [PX] 1-29 * page 153 *
 [X]  - BAILEY R. ET AL, "Chronic L-DOPA treatment of mice: a behavioural and biochemical study", J NEURAL TRANSMISSION, (1981), vol. 50, pages 209 - 224, XP000989770 [X] 1-10,22-29 * abstract * * siehe Discussion; page 214 - page 215; figure 2; table 2 *

DOI:   http://dx.doi.org/10.1007/BF01249143
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.